MarketCap
Facebook
X
TelegramHancock Jaffe Laboratories, Inc. Revenue | HJLI
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Hancock Jaffe Laboratories, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.25 K | 31.2 K | 187 K | 422 K | 786 K | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 786 K | 4.25 K | 286 K |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Vivos Therapeutics
VVOS
|
17.4 M | $ 0.13 | -2.84 % | $ 1.34 M |  USA |
 |
Beyond Air
XAIR
|
7.68 M | $ 2.2 | 5.26 % | $ 18.3 B | USA |
 |
Xtant Medical Holdings
XTNT
|
134 M | $ 0.29 | 1.31 % | $ 40.5 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
8.23 B | $ 96.52 | -2.08 % | $ 19.1 B | USA |
 |
Align Technology
ALGN
|
4.03 B | $ 151.34 | -2.05 % | $ 11 B | USA |
 |
Abbott Laboratories
ABT
|
44.3 B | $ 104.05 | 0.35 % | $ 181 B | USA |
 |
AdaptHealth Corp.
AHCO
|
3.24 B | $ 5.91 | -1.91 % | $ 799 M | USA |
 |
Alphatec Holdings
ATEC
|
764 M | $ 10.96 | -1.4 % | $ 1.64 B | USA |
 |
Bio-Rad Laboratories
BIO
|
2.58 B | $ 372.06 | 0.45 % | $ 10.1 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
400 M | $ 10.09 | 3.38 % | $ 736 M |  Israel |
 |
Electromed
ELMD
|
73.8 M | $ 26.86 | 2.05 % | $ 222 M | USA |
 |
Establishment Labs Holdings
ESTA
|
211 M | $ 66.58 | 4.35 % | $ 1.97 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
52.7 M | $ 0.74 | -0.75 % | $ 12.5 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
6.07 B | $ 89.91 | 0.91 % | $ 52.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
6.02 M | $ 2.23 | -1.33 % | $ 49.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
236 M | $ 23.71 | -3.22 % | $ 556 M | USA |
 |
MiMedx Group
MDXG
|
419 M | $ 3.87 | -1.02 % | $ 572 M | USA |
 |
EDAP TMS S.A.
EDAP
|
64.1 M | - | - | $ 162 M |  France |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | USA |
 |
Avanos Medical
AVNS
|
701 M | $ 24.99 | - | $ 1.16 B | USA |
 |
Aziyo Biologics
AZYO
|
12.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
104 M | - | - | $ 140 M | USA |
 |
GBS
GBS
|
4.22 M | - | -0.57 % | $ 7.12 M | USA |
 |
NanoVibronix
NAOV
|
2.55 M | - | - | $ 1.08 M | USA |
 |
Ra Medical Systems
RMED
|
819 K | - | 10.0 % | $ 610 K | USA |
 |
ReWalk Robotics Ltd.
RWLK
|
22 M | - | 7.07 % | $ 66.1 M | Israel |
 |
STRATA Skin Sciences
SSKN
|
30.7 M | - | - | $ 6.6 M | USA |
 |
Orthofix Medical
OFIX
|
822 M | $ 9.7 | -1.12 % | $ 384 M |  Curacao |
 |
TransMedics Group
TMDX
|
605 M | $ 71.03 | 0.41 % | $ 2.41 B | USA |
 |
Aethlon Medical
AEMD
|
574 K | $ 5.05 | 1.78 % | $ 3.4 M | USA |
 |
AxoGen
AXGN
|
225 M | $ 38.31 | 0.64 % | $ 1.76 B | USA |
 |
Nevro Corp.
NVRO
|
409 M | - | - | $ 217 M | USA |
 |
Venus Concept
VERO
|
64.8 M | - | - | $ 726 K | USA |
 |
Eargo
EAR
|
37.2 M | - | - | $ 10.2 M | USA |
 |
Sientra
SIEN
|
25.1 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
177 M | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
82 M | - | -32.98 % | $ 1.68 M | USA |
 |
Butterfly Network
BFLY
|
97.6 M | $ 6.78 | 0.37 % | $ 1.68 B | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
ShockWave Medical
SWAV
|
730 M | - | - | $ 12.3 B | USA |
 |
Inari Medical
NARI
|
494 M | - | - | $ 4.23 B | USA |